20899 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Tetrapeptides
METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#1202Inhibitors of mammalian tight junction opening
#1203USE OF FURIN CONVERTASE INHIBITORS IN THE TREATMENT OF FIBROSIS AND SCARRING
#1204Cosmetic preparations containing PTH fragments
#1205HCV NS3-NS4A Protease Inhibition
#1206PKCdelta REGULATES NEUROINFLAMMATORY EVENTS
#1207Compositions and methods for promoting wound healing and tissue regeneration
#1208Low frequency glatiramer acetate therapy
#1209METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME
#1210Tubulysin D analogues
#1211Inhibitors of MALT1 proteolytic activity and uses thereof
#1212COMBINATION THERAPY FOR TREATING HEPATITIS VIRAL INFECTION
#1213Histidine related compounds for identifying and blocking amyloid beta ion channels
#1214Therapeutic Treatment Of Wounds
#12152-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
#1216METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS
#1217Organic compounds and their uses
#1218Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#1219Methods for reducing CD36 expression
#1220PERSONAL CARE AND COSMETIC COMPOSITION CONTAINING TETRAPEPTIDES WITH THE MOTIFS GX1X2G, PX1X2P, OR PX1X2K
#1221Methods for reducing oxidative damage
#1222Methods and compositions for the treatment of proteinuric diseases
#1223Method of treatment or prophylaxis of inflammatory pain
#1224COMBINATIONS OF HCV PROTEASE INHIBITOR(S) AND CYP3A4 INHIBITOR(S), AND METHODS OF TREATMENT RELATED THERETO
#1225SUPPRESSION AND TREATMENT OF NEUROPATHIC PAIN
#1226CD36 MODULATION AND USES THEREOF
#1227Cathepsin L mediated diseases and associated methods and products
#1228Antimicrobial compounds and formulations
#1229Derivatised proline containing peptide compounds as protease inhibitors
#1230Biogel
#1231COSMETIC FORMULATION TO TREAT ROSACEA TELANGIECTASIA
#1232Compositions for Diminishing the Appearance of Wrinkles
#1233USE OF NEUROPEPTIDE SF, ALONE OR IN COMBINATION WITH GLP-2, AS A THERAPEUTIC AGENT
#1234Modulation of activity of proneurotrophins
#1235THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES
#1236USE OF HUMAN NEUROPEPTIDE AS A THERAPEUTIC AGENT
#1237USE OF ACETYL- (ALA10, 11)-RANTES (1-14) AND/OR CALCITONIN AS ANTI-ANGIOGENIC AGENTS
#1238Benzodiazepine derivatives
#1239USE OF MELANOTROPHIN-POTENTIATING FACTOR AS A THERAPEUTIC AGENT
#1240USE OF A FIBRINOGEN RECEPTOR ANTAGONIST AND/OR FOLLICULAR GONADOTROPIN RELEASING PEPTIDE AS A THERAPEUTIC AGENT IN THE TREATMENT OF STREPTOCOCCUS PNEUMONIA INFECTION
#1241METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#1242USE OF A PLATELET FIBRINOGEN RECEPTOR HEXAPEPTIDE ANTAGONIST AND ALPHA-ENDORPHIN AS THERAPEUTIC AGENTS
#1243BIG GASTRIN I AS A THERAPEUTIC AGENT
#1244USE OF THE PEPTIDE GLY-ARG-GLY-ASP-ASN-PRO AS A THERAPEUTIC AGENT
#1245Proteinase K inhibitors, methods and compositions therefor
#1246Pharmaceutical and/or cosmetic composition containing peptides
#1247Peptidomimetic protease inhibitors
#1248Method of treatment of age-related macular degeneration
#1249METHODS AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF INFLUENZA
#1250Cosmetic and/or pharmaceutical composition comprising as an active principle at least one peptide and use of this peptide
#1251CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE
#1252Synthetic peptides reducing or removing bags formed under the lower eye contour and their use in cosmetic or dermopharmaceutical compositions
#1253Peptides for the regulation of neurotransmitter sequestration and release
#1254Compositions and methods for treatment of eye disorders
#1255COMPOSITIONS AND METHODS FOR TREATMENT OF EYE DISORDERS
#1256Hemiasterlin derivatives and uses thereof in the treatment of cancer
#1257Methods of administering a material into a patient for dermal enhancement
#1258METHODS FOR INCREASING AND MOBILIZING HEMATOPOIETIC STEM CELLS
#1259USE OF PLANT CELL MEMBRANE FOR THE TREATMENT OF OBESITY
#1260Microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics
#1261HCV protease inhibitors and uses thereof
#1262Treatment of disease by inducing cell apoptosis
#1263Cosmetic compositions
#1264Skin repair compositions comprising circadian gene activators and a synergistic combination of 1 gene activators
#1265METHOD FOR TREATING SKIN
#1266Composition effective to prevent or treat adult disease
#1267Composition for acceleration of type I collagen production
#1268Method for elevating prolactin in mammals
#1269Methods for improving the structure and function of arterioles
#1270Preventive or Therapeutic Agent for Inflammatory Ocular-Surface Diseases
#1271Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods
#1272Methods for reducing CD36 expression
#1273Method for reducing the risk, lessening the symptom, or delaying the onset of insulin resistance by administering SS-31
#1274Methods and kits for diagnosing and/or assessing severity and treating gaucher disease
#1275INHIBITORS OF PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, TUMOR FORMATION AND/OR VASCULAR LEAKAGE
#1276Elastase inhibitor and acute leukemia
#1277ApoE mimetic agents
#1278Methods for prevention and treatment of acute renal injury
#1279UV-induced dermatitis inhibitor and atopic dermatitis inhibitor
#1280COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETES
#1281Compositions and methods for promoting wound healing and tissue regeneration
#1282Neuritogenic peptides
#1283METHOD OF REDUCING THE EFFECTS OF ABeta AND COMPOSITIONS THEREFORE
#1284INHIBITORS OF AMYLOID PRECURSOR PROTEIN PROCESSING
#1285INHIBITORS OF PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, TUMOR FORMATION AND/OR VASCULAR LEAKAGE
#1286PROTEIN HYDROLYSATE WITH ANTIDIABETIC EFFECT
#1287Use of effectors of glutaminyl and glutamate cyclases
#1288Combinations of HDAC Inhibitors and Proteasome Inhibitors
#1289Method for altering hematopoietic progenitor cell adhesion, differentiation, and migration
#1290Synthetic Peptide Copolymers for Treatment and Prevention of Cardiovascular Disorders
#1291Method of treating chemotherapy-induced thrombocytopenia
#1292Detection and treatment of autoimmune disorders
#1293Combination therapy
#1294AGENT FOR CORRECTING STRESS-INDUCING NEURO-MEDIATOR, NEURO-ENDOCRINE AND METABOLIC DISTURBANCES AND METHOD FOR PREVENTING AND TREATING CONCOMITANT PATHOLOGICAL CONDITIONS
#1295Prodrugs activated by plasmin and their use in cancer chemotherapy
#1296Synthetic peptide amides
#1297INHIBITORS OF PLACENTAL GROWTH FACTOR FOR THE TREATMENT OF PATHOLOGICAL ANGIOGENESIS, PATHOLOGICAL ARTERIOGENESIS, INFLAMMATION, TUMOR FORMATION AND/OR VASCULAR LEAKAGE
#1298Compositions and methods for the diagnosis and treatment of tumor
#1299Treatment for anxiety
#1300POLYMORPHISMS IN PON1 ARE ASSOCIATED WITH ELEVATED ALANINE AMINOTRANSFERASE LEVELS AFTER XIMELAGATRAN OR TACRINE ADMINISTRATION
#1301METHODS AND COMPOSITIONS FOR TREATING CARDIAC DYSFUNCTIONS
#1302Treatment of neurological disorders
#1303In-Situ Crosslinkable Elastin-Like Polypeptides for Defect Filling in Cartilaginous Tissue Repair
#1304Immunoregulatory compositions
#1305Caspase-3 Substrate Comprising Imaging Agents
#1306Treatment of leaky or damaged tight junctions and enhancing extracellular matrix
#1307Treatment of trauma-hemorrhage with short oligopeptides
#1308Hcv Ns3-Ns4a Protease Inhibition
#1309Prodrug compounds with isoleucine
#1310Use of Derivatives of Dipeptides for the Manufacture of of a Medicament for the Treamtent of Microbial Infections
#1311Stratification
#1312β-glucuronide-linker drug conjugates
#1313Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes
#1314Dampening Humoral and Innate Immunity by Inhibition of Ppgalnact-1
#1315Small peptides and methods for inhibiting the infiltration of eosinophils into airways
#1316Small Peptides And Methods For Inhibiting The Migration Of T-Cells
#1317Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
#1318Small peptides and methods for inhibiting mucus release into airways
#1319Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
#1320Small Peptides And Methods For Treatment Of Chronic Obstruction Pulmonary Disease
#1321Small Peptides And Methods For Treatment Of Arthritis
#1322Gene introduction efficiency enhancer
#1323Dermatological compositions including oligopeptides for increasing skin sensitivity and neuronal perception
#1324IAP-binding cargo molecules and peptidomimetics for use in diagnostic and therapeutic methods
#1325AT4 RECEPTOR LIGANDS AS ANGIOGENIC, ANTI-ANGIOGENIC, AND ANTI-TUMOR AGENTS
#1326Treatment of iatrogenic disease
#1327CANCER TREATMENT METHODS USING CADHERIN ANTAGONISTS IN COMBINATION WITH ANTICANCER AGENTS
#1328Small Peptides And Methods For Stabilizing The Cell Membrane Of An Immune Cell
#1329Therapeutic uses of tri-, tetra-, penta-, and polypeptides
#1330Treatment of tumors
#1331Activation and inhibition of the immune system
#1332Composition and methods for promoting wound healing and tissue regeneration
#1333OPHTHALMIC COMPOSITIONS COMPRISING DIGLYCINE
#1334IMMUNOREGULATORY COMPOSITIONS
#1335Amino-acid containing composition for inhibiting accumulation of fat
#1336Hemiasterlin derivatives and uses thereof in the treatment of cancer
#1337Treatment of Patients with Cystic Disease by Alteration of Fibrocystin Proteolysis
#1338Methods for inhibiting pain
#1339Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry
#1340DERMATOLOGICAL USES OF THE TRIPEPTIDE MELANOCYTE STIMULATING INHIBITORY FACTOR (MIF)
#1341Use of interleukin-18 inhibitors to inhibit tumor metastasis
#1342Peptide fragments for inducing synthesis of extracellular matrix proteins
#1343Combinations of HCV protease inhibitor(s) and CYP3A4 inhibitor(s), and methods of treatment related thereto
#1344Organic compounds and their uses
#1345Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto
#1346Therapeutic agents for low HDL-cholesterolemia
#1347Agents for the treatment of viral infections
#1348Cosmetic use of at least the natural tetrapeptide Ac-Ser-Asp-Lys-Pro or one of its analogs as a skin restructuring agent
#1349Methods and compositions for treating conditions
#1350Methods for Inhibiting Proteasome and Heat Shock Protein 90
#1351Combination Therapy With Glatiramer Acetate and Riluzole
#1352Anti-aging composition, kit and method of use
#1353Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy
#1354Glatiramer acetate for use as an immuno-modulatory agent
#1355Compounds for enzyme inhibition
#1356Composition for suppressing re-elevation of cholesterol, and usage thereof
#1357Method of treating, preventing, inhibiting or reducing damage to cardiac tissue with thymosin beta 4 fragments
#1358Visualization and quantitation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers
#1359Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles
#1360Dietary and pharmaceutical compositions for management and treatment of oxidative stress
#1361Methionine aminopeptidase-2 inhibitors and methods of use thereof
#1362Method of treating multiple sclerosis
#1363Methods and compositions for diagnosis and treatment of influenza
#1364Advanced glycation end-product intermediaries and post-amadori inhibition
#1365Fast-acting oral peptide pharmaceutical products
#1366Methods for reducing CD36 expression
#1367Agent derived from tortoise spleen stimulating mammalian hemopoiesis
#1368Hydrogel compositions
#1369Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
#1370PREVENTIVE/REMEDY FOR DIABETIC COMPLICATIONS USING OLIGOPEPTIDE
#1371Inhibition of cell motility, angiogenesis, and metastasis
#1372Compositions and methods for modulating connexin hemichannels
#1373TREATMENT OF PROLIFERATIVE DISORDERS
#1374Methods for preventing or treating ischemia-reperfusion injury of the kidney
#1375Medicinal uses of mu-opioid receptor agonists
#1376Treatment of tumors using short peptides from human chorionic gonadotropin (HCG)
#1377Prodrug compounds with isoleucine
#1378Methods for reducing oxidative damage
#1379Therapeutic agents for low HDL-cholesterolemia
#1380Methionine aminopeptidase-2 inhibitors and methods of use thereof
#1381Inhibitors of signal transduction and activator of transcription 3
#1382Treatment of dry eye
#1383Use of peptidic conjugates for preparing compositions for alopecia preventive and curative treatment
#1384Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
#1385Remedy for eye diseases accompanied by optic nerve injuries
#1386Compositions and methods for treatment of eye disorders
#1387Stable rgd peptidomimetic composition
#1388Inhibiting furin with polybasic peptides
#1389Use of at least one $g(a)62 casein peptide with angiotensin i converting enzyme inhibiting activity for preparing medicines, food products and food complements
#1390Methods for improving the structure and function of arterioles
#1391Treatment of gastrointestinal distress
#1392Neuronal pain pathway
#1393Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies
#1394Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy
#1395Use of effectors of glutaminyl and glutamate cyclases
#1396Novel conjugates of polysaccharides and uses thereof
#1397Compositions capable of reducing elevated blood urea concentration
#1398Compositions and methods comprising protein activated receptor antagonists
#1399Therapeutic formulations for the treatment of beta-amyloid related diseases
#1400AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents
#1401Therapeutic agents for low HDL-cholesterolemia
#1402Method of reducing the effects of Abeta and compositions therefore
#1403Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
#1404Pharmaceutical compositions
#1405Topical skin care composition
#1406Apoptotic compounds
#1407Methods for reducing oxidative damage
#1408Reducing axon degeneration with proteasome inhibitors
#1409Treatment of pain by inhibition of caspase signaling
#1410Paclitaxel hybrid derivatives
#1411Use of —furin—“convertase” inhibitors in the treatment of fibrosis and scarring
#1412Enhancement of apoptosis by caspase-9 inhibitors
#1413Compounds for enzyme inhibition
#1414Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes
#1415Compositions and methods for treating and preventing necrosis
#1416Oral delivery of peptide pharmaceutical compositions
#1417Compounds for enzyme inhibition
#1418Hemiasterlin derivatives and uses thereof
#1419Compositions capable of reducing elevated blood urea concentration
#1420AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents
#1421Use of proteasome inhibitor in the treatment of fibrotic diseases
#1422Vitamin directed targeting therapy
#1423Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
#1424Di-, tri-, and tetra-peptides having antiangiogenic activity
#1425Compositions and methods for inhibiting abnormal cell growth
#1426Peptidomimetic protease inhibitors
#1427Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
#1428Inhibitors of proteasomal activity for stimulating hair growth
#1429Drug delivery to the inner ear and methods of using same
#1430Inhibitors of PACE4 for the treatment of arthritis
#1431Drugs ameliorating hypo-hdl cholesterolemia
#1432Glutamine for use in treating injury
#1433Elastin peptide analogs and uses thereof
#1434Methionine aminopeptidase-2 inhibitors and methods of use thereof
#1435Composition and method of treatment for urogenital conditions
#1436Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
#1437Inhibitors of proteasomal activity for stimulating hair growth
#1438Osteogenic growth oligopeptides as stimulants of hematopoiesis
#1439Magnetic resonance imaging of self-assembled biomaterial scaffolds